Mikhail Blagosklonny is a professional involved in the study of cancer and the aging process. Currently, he is based at the Roswell Park Cancer Institute where he teaches oncology. Mikhail was a student at First Pavlov State Medical University, which is located in St. Petersburg and graduated with an M.D. and Doctor of Philosophy in tentative medicine and cardiology. He went on to become an Associate Professor at New York Medical College in 2002, where he taught Medicine. He then moved to Ordway Research Institute, where he was the senior scientist up to 2009. He joined his current work place after his stint at Ordway.
Read more: https://templeofthecave.com/mikhail-blagosklonny-a-review-of-his-life-achievements/
Mikhail Blagosklonny’s Areas of Study
Blagosklonny has a vast interest in cancer studies. His research focuses on marked cancer therapies capable of preventing normal cells from damages as a result of radioactive rays or chemotherapy. He also researches on the aging mechanism (biogerontology) and anti-aging management. Mikhail Blagosklonny is also interested in molecular and cellular biology as well as medical investigations. He has carried out research on cellular senescence, signal transduction, cell cycle and anti-cancer therapeutics. He has so far managed to reveal a number of potential targets that slow-down age-related ailments and the aging course.
Blagosklonny’s Editorial Works
Apart from teaching oncology and conducting research, Blagosklonny is also involved in editorial works. He plays the role of a chief author in aging, oncotarget and cell cycle. He is also an assistant editor of biology and cancer therapy. He is also the founding and chief editor of International Journal of cancer, Autophagy, American Journal of Pathology, Cell death and differentiation as well as cancer research. Oncotarget refers to a medical journal that is published on a weekly basis. It was established in 2010, and covers the area of oncology research extensively. Its chief editors are Mikhail Blagosklonny and Andrei V. Gudkov. Mikhail has managed to write over 170 articles on his research areas. Visit ResearchGate.Net to learn more about Mikhail’s latest work.
Hypothesis on TOR Signalling’s Possible Role in Cancer and Aging
Stemming from his interest in studying aging and cancer, Mikhail came up with a hypothesis based on TOR signaling. He put forward a theory that TOR can play a possible role in the management of both aging and cancer. Mikhail proposed the use of rapamycin to extend human life.
It can be hard to imagine a life where air is a precious commodity. For some it’s almost unimaginable. But for a surprising number of people it’s simply a life they’ve grown accustomed to. In one form or another, the ability to breathe is synonymous with life itself. Even the creatures of the sea need to breathe in their own special way. When something goes wrong with someone’s ability to breathe than things can become very serious at a very rapid pace. One would think that this would also call for serious medical intervention. Cedars-Sinai, however says it’s true that this is the preferred strategy. But the unfortunate truth is that until very recently there just wasn’t a lot that could be done for most lung disorders. Lung disease simply doesn’t respond very well to conventional treatments.
That hardly means that people should give up hope though. Traditional treatments might not be up to the task. But recent breakthroughs have been able to create some amazing medicines. But what’s even more amazing is that these medicines come from the patients themselves. That’s because the treatments in question involve something known as stem cell therapy. One of the leading providers of stem cell therapy is the Lung Institute, and they have a powerful new method of helping people.
The Lung Institute focuses on using stem cells to create treatment tailored to the individual. This might well be the real secret to treating lung disorders. On their own, lung diseases (https://lunginstitute.com/lung-diseases/copd/) tend to be too complex for modern medicine. Stem cell treatment is unique in actually using the patient’s own defense and healing systems to enact a cure. It essentially combines the best that modern medicine has to offer with the best of human biology. The end result can be amazing. And the Lung Institute has had some amazing results by developing this new type of treatment.
The Lung Institute’s stem cell treatment begins by harvesting stem cells from a small sample provided by the patient. This is usually in the form of a small amount of blood or bone morrow. From here, experts at the Lung Institute are able to extract and work with the patient’s stem cells. This turns the stem cells into a potent medicine. And from there the Lung Institute is able to use the resulting medicine to help heal the patient’s lungs. It’s a new way of looking at lung disease, and it’s one that’s having some remarkable successes.
To learn more, visit lunginstitute.com.